Lenvatinib with or without stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective study

BACKGROUND AND OBJECTIVES: Patients with hepatocellular carcinoma (HCC) involving portal vein tumor thrombosis (PVTT) are presently lacking effective treatment options. We aimed to compare the efficacy and safety of lenvatinib with or without SBRT for HCC with PVTT. MATERIALS AND METHODS: This retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Xiaoquan, Xu, Zhe, Sun, Jing, Li, Wengang, Duan, Xuezhang, Wang, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259021/
https://www.ncbi.nlm.nih.gov/pubmed/37308914
http://dx.doi.org/10.1186/s13014-023-02270-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259021/
https://www.ncbi.nlm.nih.gov/pubmed/37308914
http://dx.doi.org/10.1186/s13014-023-02270-z

Ejemplares similares